Concepedia

Chanchal Goswami

CG

Statistics

Publications

15

Citations

3.6K

H-Index

15

Active since

2007

Affiliations

Medical College and Hospital, Kolkata(Current)

Tata Memorial Hospital

Eli Lilly (United States)

Hôpital Notre-Dame

Masaryk Memorial Cancer Institute

Chanchal Goswami is an author at Medical College and Hospital, Kolkata specializing in oncology, medicine, and pharmacology.

Publications per year

2007–2024

15

Publications

15

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Charles S. Fuchs, Jiří Tomášek, Filip Dumitru et al. · The Lancet · 2013 · 2.2K citations · Full text

, , +12

Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial

Feng Xu, Ahmad Awada, Rámón Colomer et al. · UNC Libraries · 2020 · 486 citations · Full text

, , +12

Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer

Ahmad Awada, Rámón Colomer, Kenichi Inoue et al. · JAMA Oncology · 2016 · 313 citations · Full text

, , +17

Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study

Walter H. Gotlieb, Frédéric Amant, Suresh H. Advani et al. · The Lancet Oncology · 2011 · 151 citations

, , +13

Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Yen‐Shen Lu, Eznal Izwadi Bin Mohd Mahidin, Hamdy A. Azim et al. · Journal of Clinical Oncology · 2024 · 79 citations · Full text

, , +17

1–5 of 15